● Recruiting

SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection

Condition: Neisseria Gonorrhoeae Infection · Sponsor: University of Washington

PhaseNA

Planned participants1800

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersYes

About this study

This study aims to test the effectiveness of using of SpeeDx Resistance Plus assay to guide treatment of Neisseria gonorrhoeae (Ng) in a sexual health clinic setting.

This description comes directly from the study's public registry record.

Talk to the study team

Angela LeClair · 206-744-0489 · achein@uw.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Public Health -- Seattle & King County Sexual Health Clinic

Seattle, Washington, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05286931